2017 No. 1114
The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2017
Made
Coming into force
At the Court at Buckingham Palace, the 15th day of November 2017
Present,
The Queen’s Most Excellent Majesty in Council
In accordance with section 2(5) of the Misuse of Drugs Act 19711 a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and approved by a resolution of each House of Parliament.
Accordingly, Her Majesty, in exercise of the powers conferred upon Her by section 2(2) of that Act, is pleased, by and with the advice of Her Privy Council, to order as follows:
Citation and commencement1
This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2017 and comes into force on the 27th November 2017.
Amendment to the Misuse of Drugs Act 1971
2
The following amendment is made to Schedule 2 to the Misuse of Drugs Act 1971.
3
In paragraph 1(a) of Part 2 (which specifies the drugs which are subject to control under that Act as Class B drugs) after “Methylphenobarbitone” insert—
N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine or MPA).
(This note is not part of the Order)